Stock News

Real-time ticker analysis, price-action alerts, and institutional-grade stock data.

PENG
$20.14-0.67%
4/7, 4:59 AM

Penguin Solutions, Inc. (NASDAQ:PENG) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Penguin Solutions, Inc. (NASDAQ: PENG - Get Free Report) have received an average recommendation of "Moderate Buy" from the nine brokerages that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and six have given a buy recommendation to

defenseworld.netView Stock
CW
$696.65-0.35%
4/7, 4:59 AM

Curtiss-Wright Corporation (NYSE:CW) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Curtiss-Wright Corporation (NYSE: CW - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seven brokerages that are presently covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year target price

defenseworld.netView Stock
VKI
$8.76+0.11%
4/7, 4:59 AM

Invesco Advantage Municipal Income Trust II (NYSEAMERICAN:VKI) Major Shareholder Of America Corp /De/ Bank Buys 3,359 Shares of Stock

Invesco Advantage Municipal Income Trust II (NYSEAMERICAN:VKI - Get Free Report) major shareholder Of America Corp /De/ Bank bought 3,359 shares of the company's stock in a transaction that occurred on Thursday, April 2nd. The shares were bought at an average price of $8.68 per share, with a total value of $29,156.12. Following the completion

defenseworld.netView Stock
REZI
$34.44-1.20%
4/7, 4:59 AM

Resideo Technologies, Inc. (NYSE:REZI) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Resideo Technologies, Inc. (NYSE: REZI - Get Free Report) have been given an average rating of "Hold" by the five research firms that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and two have given a buy recommendation

defenseworld.netView Stock
PTHS
$24.25-0.53%
4/7, 4:59 AM

Pelthos Therapeutics (NYSEAMERICAN:PTHS) Director Ezra Friedberg Sells 558 Shares

Pelthos Therapeutics Inc. (NYSEAMERICAN:PTHS - Get Free Report) Director Ezra Friedberg sold 558 shares of Pelthos Therapeutics stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an average price of $20.92, for a total transaction of $11,673.36. Following the transaction, the director owned 82,027 shares of the company's stock,

defenseworld.netView Stock
STLA
$7.29-2.54%
4/7, 4:59 AM

Stellantis: Early Signs Of Turnaround With Product Momentum And Regulatory Relief

Improving product mix, solid momentum in key markets (US and Italy), and a strong H2 pipeline support a gradual recovery in volumes and margins. Greater flexibility on EU CO₂ targets and the Leapmotor agreement reduce compliance risk, while prior restructuring actions position the company for EBIT recovery in 2026. Trading at depressed multiples, we believe Stellantis offers significant upside, with earnings recovery and capital markets day acting as potential catalysts.

seekingalpha.comView Stock
KFFB
$4.43+2.07%
4/7, 4:57 AM

Kentucky First Federal Bancorp (NASDAQ:KFFB) Share Price Passes Below Fifty Day Moving Average – Here’s What Happened

Kentucky First Federal Bancorp (NASDAQ: KFFB - Get Free Report) shares crossed below its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $4.60 and traded as low as $4.33. Kentucky First Federal Bancorp shares last traded at $4.4950, with a volume of 5,977 shares trading hands. Wall Street

defenseworld.netView Stock
IOVA
$3.27-0.91%
4/7, 4:57 AM

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Cross Below 50 Day Moving Average – Here’s What Happened

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA - Get Free Report)'s share price passed below its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $3.42 and traded as low as $3.28. Iovance Biotherapeutics shares last traded at $3.30, with a volume of 9,777,900 shares traded. Wall Street Analyst Weigh In

defenseworld.netView Stock
REAL-TIME FEEDTERMINAL PAGE 15